Structural Heart Imaging Market Report Scope & Overview:
The structural heart imaging market size was valued at USD 9.54 billion in 2024 and is expected to reach USD 15.09 billion by 2032, growing at a CAGR of 6.04% over the forecast period of 2025-2032.
The global structural heart imaging market is also driven by the growing global aging population, which is leading to an increase in the incidence of structural heart diseases that require enhanced imaging support. Moreover, increasing uptake of such minimally invasive and transcatheter procedures as TAVR and MitraClip a significant contributor, since these rely heavily on high-resolution imaging. This is indicative of a strong structural heart imaging market trend towards non-invasive, precision-directed cardiac procedures, thereby pushing market growth.
For instance, in February 2025, global structural heart imaging utilization among patients aged 65+ rose 22%, driven by increasing age-related heart disorders.
Key Structural Heart Imaging Market Trends
-
Advanced imaging for accurate structural heart assessment and procedural planning.
-
Enhances diagnostic accuracy, workflow efficiency, and predictive analytics in structural heart imaging.
-
Imaging is critical for TAVR, MitraClip, and other catheter-based interventions.
-
Higher prevalence of valvular and structural heart diseases among the elderly drives imaging demand.
-
Rising cardiovascular care facilities in Asia-Pacific and Latin America.
-
Trend toward safer, high-resolution, patient-friendly structural heart diagnostics.
Structural Heart Imaging Market Report Highlights
The U.S. structural heart imaging market was valued at USD 3.12 billion in 2024 and is expected to reach USD 4.89 billion by 2032, growing at a CAGR of 5.80% over 2025-2032. The US is highly focused on research and clinical trials and is a market leader in structural heart therapies in the Structural Heart Imaging Market. An increasing number of trials necessitating high-quality imaging for diagnosis, pre-intervention planning, and follow-up are driving the uptake of the technology. This dynamic is brought into focus in this new structural heart imaging market analysis as one of the factors supporting market leadership and innovation in Spain.
The global structural heart imaging market is projected to register high demand during the forecast period, owing to increasing incidence of cardiovascular diseases and structural heart diseases, the growing adoption of 3D/4D echocardiography, cardiac CT, and AI-based imaging and the rising preference for minimally invasive and transcatheter procedures, among others, as a result of continuous technological advances and the increasing healthcare infrastructure globally.
Key Structural Heart Imaging Market Segment Analysis
-
By Modality, angiogram held the largest share of around 37.82% in 2024, and the CT segment is expected to register the highest growth with a CAGR of 7.03%.
-
By Application, the interventional cardiology segment dominated the market with approximately 71.17% share in 2024, and is expected to register the highest growth with a CAGR of 6.19%.
-
By Procedure, transcatheter aortic valve replacement (TAVR) accounted for the leading share of nearly 32.88% in 2024, whereas transcatheter mitral valve repair (TMVR) is expected to register the highest growth with a CAGR of 6.74%.
-
By End User, the hospitals & clinics segment led the market with about 52.88% share in 2024, while the ambulatory surgical centers segment is forecasted to grow the fastest at a CAGR of 6.51%.
By Modality, Angiogram Lead Market and CT Register Fastest Growth
In 2024, the angiogram segment held a demanding revenue of around 37.82% in the structural heart imaging market share and is expected to continue its dominance, due to high accuracy in visualization of coronary and structural heart diseases, common use in pre- and post-procedures, and being preferred by cardiologists for assistance in non-invasive and transcatheter interventions. The CT segment is projected to experience the fastest CAGR growth of around 7.03%, driven by high-resolution imaging, fast scan times, non-invasive feasibility, and growing use for transcatheter applications for precise diagnosis and procedural planning.
By Application, Interventional Cardiology Dominates and Shows Rapid Growth Over the Forecast Period
The structural heart imaging industry was dominated by the interventional cardiology segment with a revenue share of over 71.17% in 2024, as it depends on accurate imaging for its minimally invasive procedures, including TAVR and MitraClip, supporting accurate diagnosis, procedural planning, and real-time guidance that leads to more structural heart imaging technologies. On the other hand, it is anticipated to record the fastest CAGR of 6.19% during the forecast period (2024-2032), due to the growing number of minimally invasive procedures, increasing prevalence of cardiovascular diseases, and technological advancements in imaging for accurate diagnosis and treatment.
By Procedure, TAVR Lead, Whereas TMVR Registers the Fastest Growth
The TAVR segment led the structural heart imaging industry with the highest revenue market share of about 32.88% in 2024, owing to the increasing preference for less invasive aortic valve procedures, reliance on high-resolution imaging for pre-procedural preparation, intra-procedural guidance, and post-procedural assessment, promoting its widespread utilization. The TMVR segment is likely to register the fastest CAGR of approximately 6.74% over the forecast years 2024-2032, driven by the increasing prevalence of mitral valve disease, rising adoption of minimally invasive procedures, and the growing dependence of valvuloplasty and valvulotomy on imaging for precise placement and guidance.
By End User, Hospitals & Clinics Lead, While Ambulatory Surgical Centers Grow the Fastest
The hospitals & clinics segment of the structural heart imaging industry was estimated as the highest earning segment with a revenue share of around 52.88% in 2024, owing to their high level of infrastructural support, access to premium imaging facilities and expertise in interventional cardiology, along with high patient numbers accessing broad scope of services including diagnostic assessment, procedural planning, and follow-up related to structural heart interventions. The ambulatory surgical centers segment is projected to attain the highest CAGR of approximately 6.51% throughout the forecast period (2024-2032), fueled by the rising number of minimally invasive procedures, economical imaging services, patient preference for outpatient care, and growing ASC infrastructure globally.
Asia Pacific Structural Heart Imaging Market Insights
The Asia Pacific segment is projected to witness the fastest CAGR of 6.84% during the forecast period of 2024–2032, owing to the increasing incidence of cardiovascular and structural heart diseases, the growing geriatric population, and the rise in healthcare infrastructure. Moreover, increasing consciousness, early diagnosis-related government efforts by the governing body, a surge in acceptance of technologically advanced imaging techniques, including 4D/3D echocardiography & cardiac CT, and growing minimally invasive techniques are expected to drive the market across China, India, and Japan.
North America Structural Heart Imaging Market Insights
North America accounted for the highest revenue share of approximately 38.76% in 2024 of the Structural Heart Imaging Market, driven by its strong medical infrastructure, high incidence of cardiovascular and structural heart diseases, and early applications of modern imaging modalities, e.g., 3D/4D echocardiography, cardiac CT, and artificial intelligence (AI) driven imaging. Furthermore, the area’s favorable reimbursement scenario, increase in adoption of minimally invasive and transcatheter surgeries, high prevalence rates, and strong clinical research activity make it the most advanced and largest market for cardiac surgeries.
Europe Structural Heart Imaging Market Insights
The Europe structural heart imaging market is growing steadily due to the aging of the population is a key factor that has enabled Europe to hold a leading position in the structural heart imaging market. Furthermore, tight regulatory standards lead to high-quality imaging adoption, and public–private partnerships in healthcare have resulted in the deployment of advanced diagnostic technology in hospitals and cardiac centers.
Latin America (LATAM) and Middle East & Africa (MEA) Structural Heart Imaging Market Insights
The Middle East & Africa and Latin America markets are also increasing, owing to increasing incidence rates of cardiovascular diseases, a rise in the geriatric population, and an increase in health awareness. The market growth is driven by the expansion of advanced cardiac care centers, rising acceptance of minimally invasive procedures, and the development of new imaging infrastructure. Government programs and collaborations with private companies are further increasing the accessibility of 3D/4D echocardiography, cardiac CT, and MRI technology in these regions.
Structural Heart Imaging Market Growth Drivers:
-
Increasing Healthcare Infrastructure in Emerging Markets is Driving the Structural Heart Imaging Market Growth
Rise in awareness of animal health is also one of the key factors for the growth of the Structural Heart Imaging Market. Growth in pet owners’ concern regarding healthy nutrition, weight monitoring, and pets' well-being is driving the demand for automated feeders. With accurate portion control, purring schedules, and any monitoring, they are designed to allow owners to take care of their pets' health and obesity while also sharing their diets.
For instance, in January 2025, Global 3D/4D echocardiography usage in structural heart imaging grew 15% in 2024, reflecting advanced technology adoption and improved diagnostics.
Structural Heart Imaging Market Restraints:
-
Skilled Personnel Requirement is Hampering the Structural Heart Imaging Market Growth
The complex knowledge and technical skills needed to run and interpret structural heart imaging systems (3D/4D echocardiography, cardiac computed tomography, and magnetic resonance imaging) impair their use in areas with a lack of adequately trained cardiologists and technicians. This limitation is likely to hinder the structural heart imaging market growth, especially in emerging markets and smaller healthcare settings having limited expertise.
Structural Heart Imaging Market Opportunities:
-
Integration of AI and Machine Learning, Significant Growth Opportunities in the Structural Heart Imaging Market
The use of AI and machine learning in structural heart imaging offers major potential, improving diagnostic accuracy, predictive analytics, and workflow. The firms’ institutions and care centers will gain an edge over competitors when they choose AI-driven imaging, as control over the structural heart imaging market affects profit margins and hastens technology upgrades globally.
For instance, in January 2025Top of Form, Global AI-assisted echocardiography adoption increased 18% in 2024, enhancing diagnostic accuracy and workflow efficiency in structural heart imaging.
Competitive Landscape for Structural Heart Imaging Market:
GE HealthCare is one of the world’s largest suppliers of medical imaging equipment, including 3D/4D echocardiography, cardiac CT, and MRI technology. The company concentrates on embedding AI/machine learning into the cardiac imaging infrastructure to improve diagnostic consistency, increase efficiency in workflow, and improve patient outcomes, and continues to build strong data for powering AI throughout hospitals and heart centers globally.
-
In March 2025, GE HealthCare experienced a 12% year-on-year increase in cardiac imaging system sales, driven by the growing adoption of 3D/4D echocardiography and AI-assisted imaging, reflecting strong global demand.
Philips Healthcare is focused on cardiac imaging with 3D/4D echocardiography, cardiac CT, and AI-based imaging systems. The company’s focus is on innovation in non-invasive diagnostics to support transcatheter procedures in the structural heart market, and it has contributed a rich portfolio of tools and devices to facilitate structural heart interventions globally.
-
In February 2025, Philips Healthcare’s structural heart imaging revenue grew 15% in 2024, led by increased adoption of cardiac CT and 3D/4D echocardiography in North America and Europe, showcasing expanding market penetration.
Siemens Healthineers provides a broad range of solutions in cardiovascular imaging, including CT, MRI, echocardiography, and fusion imaging. Their emphasis on the intersection of AI-driven diagnostics, workflow enhancement, and precision guided cardiac interventions uniquely positions them to be a market leader in structural heart imaging in both developed and emerging markets.
-
In January 2025, Siemens Healthineers recorded a 10% global increase in structural heart imaging installations, driven by the adoption of cardiac CT and AI-enabled echocardiography, strengthening their market position globally.
Structural Heart Imaging Market Key Players:
Some of the Structural Heart Imaging Market Companies
-
GE HealthCare
-
Philips Healthcare
-
Siemens Healthineers
-
Canon Medical Systems
-
Hitachi Medical Systems
-
Fujifilm Holdings Corporation
-
Mindray Medical International
-
Samsung Medison
-
Neusoft Medical Systems
-
Toshiba Medical
-
Esaote
-
Edan Instruments
-
Chison Medical Technologies
-
SonoScape
-
Koninklijke Philips N.V.
-
GE Vivid
-
Shimadzu Corporation
-
Analogic Corporation
-
B-K Medical
-
Fukuda Denshi
Report Attributes | Details |
---|---|
Market Size in 2024 | USD 9.45 billion |
Market Size by 2032 | USD 15.09 billion |
CAGR | CAGR of 6.04% From 2025 to 2032 |
Base Year | 2024 |
Forecast Period | 2025-2032 |
Historical Data | 2021-2023 |
Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
Key Segments | • By Modality (Echocardiogram, Angiogram, CT, MRI, Nuclear Imaging, Other Modalities) • By Application (Diagnostic Imaging, Interventional Cardiology) • By Procedure (Transcatheter Aortic Valve Replacement (TAVR), Surgical Aortic Valve Replacement (SAVR), Transcatheter Mitral Valve Repair (TMVR), Left Atrial Appendage Closure (LAAC), Tricuspid Valve Replacement and Repair) • By End User (Hospitals & Clinics, Ambulatory Surgical Centers, Diagnostic Imaging Centers, Other End Use) |
Regional Analysis/Coverage | North America (US, Canada), Europe (Germany, France, UK, Italy, Spain, Poland, Russsia, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Australia,ASEAN Countries, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, Egypt, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Mexico, Colombia Rest of Latin America) |
Company Profiles | GE HealthCare, Philips Healthcare, Siemens Healthineers, Canon Medical Systems, Hitachi Medical Systems, Fujifilm Holdings Corporation, Mindray Medical International, Samsung Medison, Neusoft Medical Systems, Toshiba Medical, Esaote, Edan Instruments, Chison Medical Technologies, SonoScape, Koninklijke Philips N.V., GE Vivid, Shimadzu Corporation, Analogic Corporation, B-K Medical, Fukuda Denshi and other players. |
Table of Contents
1. Introduction
1.1 Market Definition & Scope
1.2 Research Assumptions & Abbreviations
1.3 Research Methodology
2. Executive Summary
2.1 Market Snapshot
2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2021–2032
2.3 Market Size & Forecast, By Segmentation, 2021–2032
2.3.1 Market Size By Modality
2.3.2 Market Size By Application
2.3.2 Market Size By Procedure
2.3.2 Market Size By End User
2.4 Market Share & Bps Analysis By Region, 2024
2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic
2.6 Industry CxO’s Perspective
3. Market Overview
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Key Market Trends
3.2 Industry PESTLE Analysis
3.3 Key Industry Forces (Porter’s) Impacting Market Growth
3.4 Industry Supply Chain Analysis
3.4.1 Raw Material Suppliers
3.4.2 Manufacturers
3.4.3 Distributors/Suppliers
3.4.4 Customers/End-Users
3.5 Industry Life Cycle Assessment
3.6 Parent Market Overview
3.7 Market Risk Assessment
4. Statistical Insights & Trends Reporting
4.1 Procedure Volume & Adoption Trends (2020–2032)
4.1.1 Global and regional adoption of structural heart imaging procedures
4.1.2 Growth rate comparison: echocardiography, CT, and MRI in structural heart evaluations
4.1.3 Elective interventions (valve replacement, repair) vs emergency imaging volumes
4.2 Patient Demographics and Utilization (2024)
4.2.1 Age-wise and gender-wise distribution of patients undergoing structural heart imaging
4.2.2 Urban vs rural access to advanced cardiac imaging modalities
4.2.3 Insurance and reimbursement coverage patterns for structural heart imaging
4.3 Technology & Infrastructure Trends (2020–2024)
4.3.1 Adoption of 3D/4D echocardiography, AI-enabled imaging, and fusion imaging
4.3.2 Distribution of imaging equipment across hospitals, specialty cardiac centers, and ASCs
4.3.3 Average investment per facility in imaging infrastructure and staff expertise
4.4 Reimbursement and Payer Mix Analysis (2024)
4.4.1 Share of imaging procedures reimbursed by Medicare, Medicaid, private payers, and out-of-pocket
4.4.2 Reimbursement rate comparison: structural heart imaging vs general cardiology imaging
4.4.3 Emerging bundled payments and value-based care models for structural heart interventions
4.5 Cost & Pricing Dynamics (2024)
4.5.1 Average cost per imaging modality in structural heart procedures (echo, CT, MRI)
4.5.2 Cross-specialty price comparison in major cardiac centers and imaging labs
4.5.3 Trends in price transparency, patient awareness, and preference for non-invasive imaging
5. Structural Heart Imaging Market Segmental Analysis & Forecast, By Modality, 2021 – 2032, Value (USD Billion)
5.1 Introduction
5.2 Echocardiogram
5.2.1 Key Trends
5.2.2 Market Size & Forecast, 2021 – 2032
5.3 Angiogram
5.3.1 Key Trends
5.3.2 Market Size & Forecast, 2021 – 2032
5.4 CT
5.4.1 Key Trends
5.4.2 Market Size & Forecast, 2021 – 2032
5.5 MRI
5.5.1 Key Trends
5.5.2 Market Size & Forecast, 2021 – 2032
5.6 Nuclear Imaging
5.6.1 Key Trends
5.6.2 Market Size & Forecast, 2021 – 2032
5.7 Other Modalities
5.7.1 Key Trends
5.7.2 Market Size & Forecast, 2021 – 2032
6. Structural Heart Imaging Market Segmental Analysis & Forecast, By Application, 2021 – 2032, Value (USD Billion)
6.1 Introduction
6.2 Diagnostic Imaging
6.2.1 Key Trends
6.2.2 Market Size & Forecast, 2021 – 2032
6.3 Interventional Cardiology
6.3.1 Key Trends
6.3.2 Market Size & Forecast, 2021 – 2032
7. Structural Heart Imaging Market Segmental Analysis & Forecast, By Procedure, 2021 – 2032, Value (USD Billion)
7.1 Introduction
7.2 Transcatheter Aortic Valve Replacement (TAVR)
7.2.1 Key Trends
7.2.2 Market Size & Forecast, 2021 – 2032
7.3 Surgical Aortic Valve Replacement (SAVR)
7.3.1 Key Trends
7.3.2 Market Size & Forecast, 2021 – 2032
7.4 Transcatheter Mitral Valve Repair (TMVR)
7.4.1 Key Trends
7.4.2 Market Size & Forecast, 2021 – 2032
7.5 Left Atrial Appendage Closure (LAAC)
7.5.1 Key Trends
7.5.2 Market Size & Forecast, 2021 – 2032
7.6 Tricuspid Valve Replacement and Repair
7.6.1 Key Trends
7.6.2 Market Size & Forecast, 2021 – 2032
8. Structural Heart Imaging Market Segmental Analysis & Forecast, By End User, 2021 – 2032, Value (USD Billion)
8.1 Introduction
8.2 Hospitals & Clinics
8.2.1 Key Trends
8.2.2 Market Size & Forecast, 2021 – 2032
8.3 Ambulatory Surgical Centers
8.3.1 Key Trends
8.3.2 Market Size & Forecast, 2021 – 2032
8.4 Diagnostic Imaging Centers
8.4.1 Key Trends
8.4.2 Market Size & Forecast, 2021 – 2032
8.5 Other End User
8.5.1 Key Trends
8.5.2 Market Size & Forecast, 2021 – 2032
9. Structural Heart Imaging Market Segmental Analysis & Forecast By Region, 2021 – 2025, Value (USD Billion)
9.1 Introduction
9.2 North America
9.2.1 Key Trends
9.2.2 Structural Heart Imaging Market Size & Forecast, By Modality, 2021 – 2032
9.2.3 Structural Heart Imaging Market Size & Forecast, By Application, 2021 – 2032
9.2.4 Structural Heart Imaging Market Size & Forecast, By Procedure, 2021 – 2032
9.2.5 Structural Heart Imaging Market Size & Forecast, By End User, 2021 – 2032
9.2.6 Structural Heart Imaging Market Size & Forecast, By Country, 2021 – 2032
9.2.6.1 USA
9.2.6.1.1 Structural Heart Imaging Market Size & Forecast, By Modality, 2021 – 2032
9.2.6.1.2 Structural Heart Imaging Market Size & Forecast, By Application, 2021 – 2032
9.2.6.1.3 Structural Heart Imaging Market Size & Forecast, By Procedure, 2021 – 2032
9.2.6.1.4 Structural Heart Imaging Market Size & Forecast, By End User, 2021 – 2032
9.2.6.2 Canada
9.2.6.2.1 Structural Heart Imaging Market Size & Forecast, By Modality, 2021 – 2032
9.2.6.2.2 Structural Heart Imaging Market Size & Forecast, By Application, 2021 – 2032
9.2.6.2.3 Structural Heart Imaging Market Size & Forecast, By Procedure, 2021 – 2032
9.2.6.2.4 Structural Heart Imaging Market Size & Forecast, By End User, 2021 – 2032
9.3 Europe
9.3.1 Key Trends
9.3.2 Structural Heart Imaging Market Size & Forecast, By Modality, 2021 – 2032
9.3.3 Structural Heart Imaging Market Size & Forecast, By Application, 2021 – 2032
9.3.4 Structural Heart Imaging Market Size & Forecast, By Procedure, 2021 – 2032
9.3.5 Structural Heart Imaging Market Size & Forecast, By End User, 2021 – 2032
9.3.6 Structural Heart Imaging Market Size & Forecast, By Country, 2021 – 2032
9.3.6.1 Germany
9.3.6.1.1 Structural Heart Imaging Market Size & Forecast, By Modality, 2021 – 2032
9.3.6.1.2 Structural Heart Imaging Market Size & Forecast, By Application, 2021 – 2032
9.3.6.1.3 Structural Heart Imaging Market Size & Forecast, By Procedure, 2021 – 2032
9.3.6.1.4 Structural Heart Imaging Market Size & Forecast, By End User, 2021 – 2032
9.3.6.2 UK
9.3.6.2.1 Structural Heart Imaging Market Size & Forecast, By Modality, 2021 – 2032
9.3.6.2.2 Structural Heart Imaging Market Size & Forecast, By Application, 2021 – 2032
9.3.6.2.3 Structural Heart Imaging Market Size & Forecast, By Procedure, 2021 – 2032
9.3.6.2.4 Structural Heart Imaging Market Size & Forecast, By End User, 2021 – 2032
9.3.6.3 France
9.3.6.3.1 Structural Heart Imaging Market Size & Forecast, By Modality, 2021 – 2032
9.3.6.3.2 Structural Heart Imaging Market Size & Forecast, By Application, 2021 – 2032
9.3.6.3.3 Structural Heart Imaging Market Size & Forecast, By Procedure, 2021 – 2032
9.3.6.3.4 Structural Heart Imaging Market Size & Forecast, By End User, 2021 – 2032
9.3.6.4 Italy
9.3.6.4.1 Structural Heart Imaging Market Size & Forecast, By Modality, 2021 – 2032
9.3.6.4.2 Structural Heart Imaging Market Size & Forecast, By Application, 2021 – 2032
9.3.6.4.3 Structural Heart Imaging Market Size & Forecast, By Procedure, 2021 – 2032
9.3.6.4.4 Structural Heart Imaging Market Size & Forecast, By End User, 2021 – 2032
9.3.6.5 Spain
9.3.6.5.1 Structural Heart Imaging Market Size & Forecast, By Modality, 2021 – 2032
9.3.6.5.2 Structural Heart Imaging Market Size & Forecast, By Application, 2021 – 2032
9.3.6.5.3 Structural Heart Imaging Market Size & Forecast, By Procedure, 2021 – 2032
9.3.6.5.4 Structural Heart Imaging Market Size & Forecast, By End User, 2021 – 2032
9.3.6.6 Russia
9.3.6.6.1 Structural Heart Imaging Market Size & Forecast, By Modality, 2021 – 2032
9.3.6.6.2 Structural Heart Imaging Market Size & Forecast, By Application, 2021 – 2032
9.3.6.6.3 Structural Heart Imaging Market Size & Forecast, By Procedure, 2021 – 2032
9.3.6.6.4 Structural Heart Imaging Market Size & Forecast, By End User, 2021 – 2032
9.3.6.7 Poland
9.3.6.7.1 Structural Heart Imaging Market Size & Forecast, By Modality, 2021 – 2032
9.3.6.7.2 Structural Heart Imaging Market Size & Forecast, By Application, 2021 – 2032
9.3.6.7.3 Structural Heart Imaging Market Size & Forecast, By Procedure, 2021 – 2032
9.3.6.7.4 Structural Heart Imaging Market Size & Forecast, By End User, 2021 – 2032
9.3.6.8 Rest of Europe
9.3.6.8.1 Structural Heart Imaging Market Size & Forecast, By Modality, 2021 – 2032
9.3.6.8.2 Structural Heart Imaging Market Size & Forecast, By Application, 2021 – 2032
9.3.6.8.3 Structural Heart Imaging Market Size & Forecast, By Procedure, 2021 – 2032
9.3.6.8.4 Structural Heart Imaging Market Size & Forecast, By End User, 2021 – 2032
9.4 Asia-Pacific
9.4.1 Key Trends
9.4.2 Structural Heart Imaging Market Size & Forecast, By Modality, 2021 – 2032
9.4.3 Structural Heart Imaging Market Size & Forecast, By Application, 2021 – 2032
9.4.4 Structural Heart Imaging Market Size & Forecast, By Procedure, 2021 – 2032
9.4.5 Structural Heart Imaging Market Size & Forecast, By End User, 2021 – 2032
9.4.6 Structural Heart Imaging Market Size & Forecast, By Country, 2021 – 2032
9.4.6.1 China
9.4.6.1.1 Structural Heart Imaging Market Size & Forecast, By Modality, 2021 – 2032
9.4.6.1.2 Structural Heart Imaging Market Size & Forecast, By Application, 2021 – 2032
9.4.6.1.3 Structural Heart Imaging Market Size & Forecast, By Procedure, 2021 – 2032
9.4.6.1.4 Structural Heart Imaging Market Size & Forecast, By End User, 2021 – 2032
9.4.6.2 India
9.4.6.2.1 Structural Heart Imaging Market Size & Forecast, By Modality, 2021 – 2032
9.4.6.2.2 Structural Heart Imaging Market Size & Forecast, By Application, 2021 – 2032
9.4.6.2.3 Structural Heart Imaging Market Size & Forecast, By Procedure, 2021 – 2032
9.4.6.2.4 Structural Heart Imaging Market Size & Forecast, By End User, 2021 – 2032
9.4.6.3 Japan
9.4.6.3.1 Structural Heart Imaging Market Size & Forecast, By Modality, 2021 – 2032
9.4.6.3.2 Structural Heart Imaging Market Size & Forecast, By Application, 2021 – 2032
9.4.6.3.3 Structural Heart Imaging Market Size & Forecast, By Procedure, 2021 – 2032
9.4.6.3.4 Structural Heart Imaging Market Size & Forecast, By End User, 2021 – 2032
9.4.6.4 South Korea
9.4.6.4.1 Structural Heart Imaging Market Size & Forecast, By Modality, 2021 – 2032
9.4.6.4.2 Structural Heart Imaging Market Size & Forecast, By Application, 2021 – 2032
9.4.6.4.3 Structural Heart Imaging Market Size & Forecast, By Procedure, 2021 – 2032
9.4.6.4.4 Structural Heart Imaging Market Size & Forecast, By End User, 2021 – 2032
9.4.6.5 Australia
9.4.6.5.1 Structural Heart Imaging Market Size & Forecast, By Modality, 2021 – 2032
9.4.6.5.2 Structural Heart Imaging Market Size & Forecast, By Application, 2021 – 2032
9.4.6.5.3 Structural Heart Imaging Market Size & Forecast, By Procedure, 2021 – 2032
9.4.6.5.4 Structural Heart Imaging Market Size & Forecast, By End User, 2021 – 2032
9.4.6.6 ASEAN Countries
9.4.6.6.1 Structural Heart Imaging Market Size & Forecast, By Modality, 2021 – 2032
9.4.6.6.2 Structural Heart Imaging Market Size & Forecast, By Application, 2021 – 2032
9.4.6.6.3 Structural Heart Imaging Market Size & Forecast, By Procedure, 2021 – 2032
9.4.6.6.4 Structural Heart Imaging Market Size & Forecast, By End User, 2021 – 2032
9.4.6.7 Rest of Asia-Pacific
9.4.6.7.1 Structural Heart Imaging Market Size & Forecast, By Modality, 2021 – 2032
9.4.6.7.2 Structural Heart Imaging Market Size & Forecast, By Application, 2021 – 2032
9.4.6.7.3 Structural Heart Imaging Market Size & Forecast, By Procedure, 2021 – 2032
9.4.6.7.4 Structural Heart Imaging Market Size & Forecast, By End User, 2021 – 2032
9.5 Latin America
9.5.1 Key Trends
9.5.2 Structural Heart Imaging Market Size & Forecast, By Modality, 2021 – 2032
9.5.3 Structural Heart Imaging Market Size & Forecast, By Application, 2021 – 2032
9.5.4 Structural Heart Imaging Market Size & Forecast, By Procedure, 2021 – 2032
9.5.5 Structural Heart Imaging Market Size & Forecast, By End User, 2021 – 2032
9.5.6 Structural Heart Imaging Market Size & Forecast, By Country, 2021 – 2032
9.5.6.1 Brazil
9.5.6.1.1 Structural Heart Imaging Market Size & Forecast, By Modality, 2021 – 2032
9.5.6.1.2 Structural Heart Imaging Market Size & Forecast, By Application, 2021 – 2032
9.5.6.1.3 Structural Heart Imaging Market Size & Forecast, By Procedure, 2021 – 2032
9.5.6.1.4 Structural Heart Imaging Market Size & Forecast, By End User, 2021 – 2032
9.5.6.2 Argentina
9.5.6.2.1 Structural Heart Imaging Market Size & Forecast, By Modality, 2021 – 2032
9.5.6.2.2 Structural Heart Imaging Market Size & Forecast, By Application, 2021 – 2032
9.5.6.2.3 Structural Heart Imaging Market Size & Forecast, By Procedure, 2021 – 2032
9.5.6.2.4 Structural Heart Imaging Market Size & Forecast, By End User, 2021 – 2032
9.5.6.3 Mexico
9.5.6.3.1 Structural Heart Imaging Market Size & Forecast, By Modality, 2021 – 2032
9.5.6.3.2 Structural Heart Imaging Market Size & Forecast, By Application, 2021 – 2032
9.5.6.3.3 Structural Heart Imaging Market Size & Forecast, By Procedure, 2021 – 2032
9.5.6.3.4 Structural Heart Imaging Market Size & Forecast, By End User, 2021 – 2032
9.5.6.4 Colombia
9.5.6.4.1 Structural Heart Imaging Market Size & Forecast, By Modality, 2021 – 2032
9.5.6.4.2 Structural Heart Imaging Market Size & Forecast, By Application, 2021 – 2032
9.5.6.4.3 Structural Heart Imaging Market Size & Forecast, By Procedure, 2021 – 2032
9.5.6.4.4 Structural Heart Imaging Market Size & Forecast, By End User, 2021 – 2032
9.5.6.5 Rest of Latin America
9.5.6.5.1 Structural Heart Imaging Market Size & Forecast, By Modality, 2021 – 2032
9.5.6.5.2 Structural Heart Imaging Market Size & Forecast, By Application, 2021 – 2032
9.5.6.5.3 Structural Heart Imaging Market Size & Forecast, By Procedure, 2021 – 2032
9.5.6.5.4 Structural Heart Imaging Market Size & Forecast, By End User, 2021 – 2032
9.6 Middle East & Africa
9.6.1 Key Trends
9.6.2 Structural Heart Imaging Market Size & Forecast, By Modality, 2021 – 2032
9.6.3 Structural Heart Imaging Market Size & Forecast, By Application, 2021 – 2032
9.6.4 Structural Heart Imaging Market Size & Forecast, By Procedure, 2021 – 2032
9.6.5 Structural Heart Imaging Market Size & Forecast, By End User, 2021 – 2032
9.6.6 Structural Heart Imaging Market Size & Forecast, By Country, 2021 – 2032
9.6.6.1 UAE
9.6.6.1.1 Structural Heart Imaging Market Size & Forecast, By Modality, 2021 – 2032
9.6.6.1.2 Structural Heart Imaging Market Size & Forecast, By Application, 2021 – 2032
9.6.6.1.3 Structural Heart Imaging Market Size & Forecast, By Procedure, 2021 – 2032
9.6.6.1.4 Structural Heart Imaging Market Size & Forecast, By End User, 2021 – 2032
9.6.6.2 Saudi Arabia
9.6.6.2.1 Structural Heart Imaging Market Size & Forecast, By Modality, 2021 – 2032
9.6.6.2.2 Structural Heart Imaging Market Size & Forecast, By Application, 2021 – 2032
9.6.6.2.3 Structural Heart Imaging Market Size & Forecast, By Procedure, 2021 – 2032
9.6.6.2.4 Structural Heart Imaging Market Size & Forecast, By End User, 2021 – 2032
9.6.6.3 Qatar
9.6.6.3.1 Structural Heart Imaging Market Size & Forecast, By Modality, 2021 – 2032
9.6.6.3.2 Structural Heart Imaging Market Size & Forecast, By Application, 2021 – 2032
9.6.6.3.3 Structural Heart Imaging Market Size & Forecast, By Procedure, 2021 – 2032
9.6.6.3.4 Structural Heart Imaging Market Size & Forecast, By End User, 2021 – 2032
9.6.6.4 Egypt
9.6.6.4.1 Structural Heart Imaging Market Size & Forecast, By Modality, 2021 – 2032
9.6.6.4.2 Structural Heart Imaging Market Size & Forecast, By Application, 2021 – 2032
9.6.6.4.3 Structural Heart Imaging Market Size & Forecast, By Procedure, 2021 – 2032
9.6.6.4.4 Structural Heart Imaging Market Size & Forecast, By End User, 2021 – 2032
9.6.6.5 South Africa
9.6.6.5.1 Structural Heart Imaging Market Size & Forecast, By Modality, 2021 – 2032
9.6.6.5.2 Structural Heart Imaging Market Size & Forecast, By Application, 2021 – 2032
9.6.6.5.3 Structural Heart Imaging Market Size & Forecast, By Procedure, 2021 – 2032
9.6.6.5.4 Structural Heart Imaging Market Size & Forecast, By End User, 2021 – 2032
9.6.6.6 Rest of Middle East & Africa
9.6.6.6.1 Structural Heart Imaging Market Size & Forecast, By Modality, 2021 – 2032
9.6.6.6.2 Structural Heart Imaging Market Size & Forecast, By Application, 2021 – 2032
9.6.6.6.3 Structural Heart Imaging Market Size & Forecast, By Procedure, 2021 – 2032
9.6.6.6.4 Structural Heart Imaging Market Size & Forecast, By End User, 2021 – 2032
10. Competitive Landscape
10.1 Key Players' Positioning
10.2 Competitive Developments
10.2.1 Key Strategies Adopted (%), By Key Players, 2024
10.2.2 Year-Wise Strategies & Development, 2021 – 2025
10.2.3 Number Of Strategies Adopted By Key Players, 2024
10.3 Market Share Analysis, 2024
10.4 Product/Service & Application Benchmarking
10.4.1 Product/Service Specifications & Features By Key Players
10.4.2 Product/Service Heatmap By Key Players
10.4.3 Application Heatmap By Key Players
10.5 Industry Start-Up & Innovation Landscape
10.6 Key Company Profiles
10.6 Key Company Profiles
10.6.1 GE HealthCare
10.6.1.1 Company Overview & Snapshot
10.6.1.2 Product/Service Portfolio
10.6.1.3 Key Company Financials
10.6.1.4 SWOT Analysis
10.6.2 Philips Healthcare
10.6.2.1 Company Overview & Snapshot
10.6.2.2 Product/Service Portfolio
10.6.2.3 Key Company Financials
10.6.2.4 SWOT Analysis
10.6.3 Siemens Healthineers
10.6.3.1 Company Overview & Snapshot
10.6.3.2 Product/Service Portfolio
10.6.3.3 Key Company Financials
10.6.3.4 SWOT Analysis
10.6.4 Canon Medical Systems
10.6.4.1 Company Overview & Snapshot
10.6.4.2 Product/Service Portfolio
10.6.4.3 Key Company Financials
10.6.4.4 SWOT Analysis
10.6.5 Hitachi Medical Systems
10.6.5.1 Company Overview & Snapshot
10.6.5.2 Product/Service Portfolio
10.6.5.3 Key Company Financials
10.6.5.4 SWOT Analysis
10.6.6 Fujifilm Holdings Corporation
10.6.6.1 Company Overview & Snapshot
10.6.6.2 Product/Service Portfolio
10.6.6.3 Key Company Financials
10.6.6.4 SWOT Analysis
10.6.7 Mindray Medical International
10.6.7.1 Company Overview & Snapshot
10.6.7.2 Product/Service Portfolio
10.6.7.3 Key Company Financials
10.6.7.4 SWOT Analysis
10.6.8 Samsung Medison
10.6.8.1 Company Overview & Snapshot
10.6.8.2 Product/Service Portfolio
10.6.8.3 Key Company Financials
10.6.8.4 SWOT Analysis
10.6.9 Neusoft Medical Systems
10.6.9.1 Company Overview & Snapshot
10.6.9.2 Product/Service Portfolio
10.6.9.3 Key Company Financials
10.6.9.4 SWOT Analysis
10.6.10 Toshiba Medical
10.6.10.1 Company Overview & Snapshot
10.6.10.2 Product/Service Portfolio
10.6.10.3 Key Company Financials
10.6.10.4 SWOT Analysis
10.6.11 Esaote
10.6.11.1 Company Overview & Snapshot
10.6.11.2 Product/Service Portfolio
10.6.11.3 Key Company Financials
10.6.11.4 SWOT Analysis
10.6.12 Edan Instruments
10.6.12.1 Company Overview & Snapshot
10.6.12.2 Product/Service Portfolio
10.6.12.3 Key Company Financials
10.6.12.4 SWOT Analysis
10.6.13 Chison Medical Technologies
10.6.13.1 Company Overview & Snapshot
10.6.13.2 Product/Service Portfolio
10.6.13.3 Key Company Financials
10.6.13.4 SWOT Analysis
10.6.14 SonoScape
10.6.14.1 Company Overview & Snapshot
10.6.14.2 Product/Service Portfolio
10.6.14.3 Key Company Financials
10.6.14.4 SWOT Analysis
10.6.15 Koninklijke Philips N.V.
10.6.15.1 Company Overview & Snapshot
10.6.15.2 Product/Service Portfolio
10.6.15.3 Key Company Financials
10.6.15.4 SWOT Analysis
10.6.16 GE Vivid
10.6.16.1 Company Overview & Snapshot
10.6.16.2 Product/Service Portfolio
10.6.16.3 Key Company Financials
10.6.16.4 SWOT Analysis
10.6.17 Shimadzu Corporation
10.6.17.1 Company Overview & Snapshot
10.6.17.2 Product/Service Portfolio
10.6.17.3 Key Company Financials
10.6.17.4 SWOT Analysis
10.6.18 Analogic Corporation
10.6.18.1 Company Overview & Snapshot
10.6.18.2 Product/Service Portfolio
10.6.18.3 Key Company Financials
10.6.18.4 SWOT Analysis
10.6.19 B-K Medical
10.6.19.1 Company Overview & Snapshot
10.6.19.2 Product/Service Portfolio
10.6.19.3 Key Company Financials
10.6.19.4 SWOT Analysis
10.6.20 Fukuda Denshi
10.6.20.1 Company Overview & Snapshot
10.6.20.2 Product/Service Portfolio
10.6.20.3 Key Company Financials
10.6.20.4 SWOT Analysis
11. Analyst Recommendations
11.1 SNS Insider Opportunity Map
11.2 Industry Low-Hanging Fruit Assessment
11.3 Market Entry & Growth Strategy
11.4 Analyst Viewpoint & Suggestions On Market Growth
12. Assumptions
13. Disclaimer
14. Appendix
14.1 List Of Tables
14.2 List Of Figures
Key Segments:
By Modality
-
Echocardiogram
-
Angiogram
-
CT
-
MRI
-
Nuclear Imaging
-
Other Modalities
By Application
-
Diagnostic Imaging
-
Interventional Cardiology
By Procedure
-
Transcatheter Aortic Valve Replacement (TAVR)
-
Surgical Aortic Valve Replacement (SAVR)
-
Transcatheter Mitral Valve Repair (TMVR)
-
Left Atrial Appendage Closure (LAAC)
-
Tricuspid Valve Replacement and Repair
By End User
-
-
Hospitals & Clinics
-
Ambulatory Surgical Centers
-
Diagnostic Imaging Centers
-
Other End Use
-
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
-
US
-
Canada
Europe
-
Germany
-
UK
-
France
-
Italy
-
Spain
-
Russia
-
Poland
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
ASEAN Countries
-
Australia
-
Rest of Asia Pacific
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
Egypt
-
South Africa
-
Rest of Middle East & Africa
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g., Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.

Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.

Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.

Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.